-Advancing zervimesine clinical development in DLB psychosis – - Meeting with FDA Division of Psychiatry expected by mid-2026 -- Management conference call at 8:30 a.m. ET today -
-Advancing zervimesine clinical development in DLB psychosis - Meeting with FDA Division of Psychiatry expected by mid-2026 -- Management conference call at 8:30 a.m. ET today -
PURCHASE, N.Y., Mar… [+14416 chars]

